iPHEX 2026 highlights CDSCO’s shift towards smarter, risk-based pharma regulation, simpler compliance and proportionate enforcement.
Read MorePHARMEXCIL
Scaling Pharma Exports: India Targets Double-Digit Growth After Crossing USD 30 Billion
Chintan Shivir on Scaling Pharma Exports reviews $30.47B milestone, 9.4% growth and ₹10,000 crore Biopharma SHAKTI push for global expansion.
Read More